Pharmacogenetic Applications of the Post Genomic Era

E-ISSN： 1873-4316|3|2|141-150

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.3, Iss.2, 2002-01, pp. : 141-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic targets in tuberculosis: post-genomic era

By Khasnobis Shampa Escuyer Vincent E Chatterjee Delphi

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite

Identifying Biomarkers of Lung Cancer in the Post-Genomic Era

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-12 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era

Current Molecular Pharmacology, Vol. 7, Iss. 1, 2014-04 ,pp. : 33-43

Bentham Science Publishers

Access to resources Recommend Favorite

Giardiasis in the Post Genomic Era: Treatment, Drug Resistance and Novel Therapeutic Perspectives

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 4, 2010-08 ,pp. : 283-294

Bentham Science Publishers

Access to resources Recommend Favorite

Familial Mediterranean Fever in the Post-Genomic Era: How an Ancient Disease is Providing New Insights into Inflammatory Pathways

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 67-76

Bentham Science Publishers

Access to resources Recommend Favorite